Patent details
EP2722046 Title: 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
Basic Information
- Publication number:
- EP2722046
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP141510891
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1
- French Title of Invention:
- Forme 1 cristalline 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide
- German Title of Invention:
- 2-((R)-2-methylpyrrolidin-2-yl)-1H-Benzimidazol-4-Carboxamid-Kristallform 1
- SPC Number:
Dates
- Filing date:
- 10/10/2008
- Grant date:
- 21/12/2016
- EP Publication Date:
- 21/12/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/04/2014
- EP B1 Publication Date:
- 21/12/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/10/2017
- Expiration date:
- 10/10/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/10/2008
- Name:
- AbbVie Ireland Unlimited Company
- Address:
- 70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)
Inventor
- Name:
- Kolaczkowski Lawrence
- Address:
- United States (US)
Priority
- Priority Number:
- 979643 P
- Priority Date:
- 12/10/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/4184;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|